Dr. Rappo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
322 E. Main Street
3rd floor
Branford, CT 06405- Is this information wrong?
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Infectious Disease, 2009 - 2011
NYU Grossman School of MedicineResidency, Internal Medicine, 2006 - 2009
Drexel University College of MedicineClass of 2006
Certifications & Licensure
NY State Medical License 2009 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyelitis Start of enrollment: 2016 Mar 15
- Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis Start of enrollment: 2017 May 12
Publications & Presentations
PubMed
- 1 citationsDalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infection in Patients With Obesity or Diabetes: A Subgroup Analysis of Pooled Phase 3 Clinical...Todd Riccobene, John Lock, Rosie D Lyles, Benjamin Georgiades, Michael Nowak, Pedro L Gonzalez, Jenny Park, Urania Rappo> ;Open Forum Infectious Diseases. 2023 Jun 1
- 132 citationsTargeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation.Sara Federici, Sharon Kredo-Russo, Rafael Valdés-Mas, Denise Kviatcovsky, Eyal Weinstock, Yulia Matiuhin, Yael Silberberg, Koji Atarashi, Munehiro Furuichi, Akihiko Ok...> ;Cell. 2022 Aug 4
- 17 citationsDalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial.Nicholas A Turner, Smitha Zaharoff, Heather King, Scott Evans, Toshimitsu Hamasaki, Thomas Lodise, Varduhi Ghazaryan, Tatiana Beresnev, Todd Riccobene, Rinal Patel, Sa...> ;Trials. 2022 May 16
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
